BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

RUNX1, RUNX3, CBFB and PMP22 as targets for neurofibromatosis

Claire Quang
April 30, 2019 12:59 PM UTC

INDICATION: Neurofibromatosis...

BCIQ Company Profiles

University of Cincinnati

BCIQ Target Profiles

Core-binding factor beta subunit (CBFB) (CBFbeta)

Peripheral myelin protein 22 (PMP22)

Runt-related transcription factor 1 (RUNX1) (AML1)

Runt-related transcription factor 3 (RUNX3)

BCIQ Company Profiles

University of Cincinnati

BCIQ Target Profiles

Core-binding factor beta subunit (CBFB) (CBFbeta)

Peripheral myelin protein 22 (PMP22)

Runt-related transcription factor 1 (RUNX1) (AML1)

Runt-related transcription factor 3 (RUNX3)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS